Livzon Pharmaceutical Group Inc (000513) — Working Capital to Net Assets Ratio
Livzon Pharmaceutical Group Inc (000513) has a Working Capital to Net Assets ratio of 60.0% as of September 2025. Working capital of CN¥9.21 Billion (current assets of CN¥16.57 Billion minus current liabilities of CN¥7.36 Billion) is measured against net assets of CN¥15.37 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Livzon Pharmaceutical Group Inc (000513) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Livzon Pharmaceutical Group Inc Working Capital to Net Assets (1992–2024)
This chart shows how Livzon Pharmaceutical Group Inc's Working Capital to Net Assets ratio has evolved across 33 annual periods from 1992 to 2024. As of September 2025, the ratio stands at 60.0%, reflecting working capital of CN¥9.21 Billion against net assets of CN¥15.37 Billion CNY. Check Livzon Pharmaceutical Group Inc (000513) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Livzon Pharmaceutical Group Inc (1992–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Livzon Pharmaceutical Group Inc from 1992 to 2024, covering 33 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 000513 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 59.0% | CN¥8.79 Billion | CN¥14.91 Billion | CN¥16.42 Billion | CN¥7.63 Billion | ▼ -3.2 pp |
| 2023 | 62.2% | CN¥9.18 Billion | CN¥14.77 Billion | CN¥17.27 Billion | CN¥8.09 Billion | ▼ -2.1 pp |
| 2022 | 64.2% | CN¥9.59 Billion | CN¥14.94 Billion | CN¥16.99 Billion | CN¥7.40 Billion | ▲ +10.1 pp |
| 2021 | 54.1% | CN¥7.75 Billion | CN¥14.31 Billion | CN¥14.67 Billion | CN¥6.93 Billion | ▼ -8.5 pp |
| 2020 | 62.6% | CN¥8.54 Billion | CN¥13.64 Billion | CN¥14.63 Billion | CN¥6.08 Billion | ▲ +0.9 pp |
| 2019 | 61.7% | CN¥7.58 Billion | CN¥12.28 Billion | CN¥12.87 Billion | CN¥5.29 Billion | ▲ +1.3 pp |
| 2018 | 60.4% | CN¥7.10 Billion | CN¥11.75 Billion | CN¥12.47 Billion | CN¥5.37 Billion | ▼ -1.3 pp |
| 2017 | 61.8% | CN¥6.94 Billion | CN¥11.23 Billion | CN¥11.35 Billion | CN¥4.41 Billion | ▲ +24.3 pp |
| 2016 | 37.4% | CN¥2.66 Billion | CN¥7.11 Billion | CN¥5.97 Billion | CN¥3.31 Billion | ▲ +28.6 pp |
| 2015 | 8.8% | CN¥422.94 Million | CN¥4.81 Billion | CN¥3.58 Billion | CN¥3.15 Billion | ▼ -3.4 pp |
| 2014 | 12.2% | CN¥496.71 Million | CN¥4.08 Billion | CN¥3.17 Billion | CN¥2.67 Billion | ▼ -5.9 pp |
| 2013 | 18.1% | CN¥651.05 Million | CN¥3.60 Billion | CN¥2.98 Billion | CN¥2.33 Billion | ▼ -0.7 pp |
| 2012 | 18.8% | CN¥597.69 Million | CN¥3.18 Billion | CN¥2.97 Billion | CN¥2.38 Billion | ▼ -27.3 pp |
| 2011 | 46.1% | CN¥1.39 Billion | CN¥3.01 Billion | CN¥2.91 Billion | CN¥1.52 Billion | ▼ -0.6 pp |
| 2010 | 46.6% | CN¥1.23 Billion | CN¥2.64 Billion | CN¥2.16 Billion | CN¥925.21 Million | ▼ -1.2 pp |
| 2009 | 47.8% | CN¥1.06 Billion | CN¥2.23 Billion | CN¥1.84 Billion | CN¥777.21 Million | ▲ +12.8 pp |
| 2008 | 35.0% | CN¥642.48 Million | CN¥1.83 Billion | CN¥1.61 Billion | CN¥967.37 Million | ▼ -2.6 pp |
| 2007 | 37.7% | CN¥749.62 Million | CN¥1.99 Billion | CN¥1.59 Billion | CN¥836.45 Million | ▲ +22.5 pp |
| 2006 | 15.2% | CN¥209.13 Million | CN¥1.38 Billion | CN¥1.16 Billion | CN¥947.09 Million | ▲ +20.3 pp |
| 2005 | -5.1% | CN¥-63.73 Million | CN¥1.24 Billion | CN¥844.22 Million | CN¥907.95 Million | ▼ -15.9 pp |
| 2004 | 10.8% | CN¥126.08 Million | CN¥1.17 Billion | CN¥1.05 Billion | CN¥919.70 Million | ▼ -3.4 pp |
| 2003 | 14.2% | CN¥166.70 Million | CN¥1.17 Billion | CN¥1.06 Billion | CN¥896.39 Million | ▼ -15.1 pp |
| 2002 | 29.3% | CN¥330.70 Million | CN¥1.13 Billion | CN¥975.31 Million | CN¥644.61 Million | ▲ +3.0 pp |
| 2001 | 26.3% | CN¥272.92 Million | CN¥1.04 Billion | CN¥911.74 Million | CN¥638.82 Million | ▲ +0.1 pp |
| 2000 | 26.2% | CN¥263.88 Million | CN¥1.01 Billion | CN¥794.60 Million | CN¥530.72 Million | ▼ -4.4 pp |
| 1999 | 30.6% | CN¥298.22 Million | CN¥973.90 Million | CN¥823.31 Million | CN¥525.09 Million | ▼ -2.3 pp |
| 1998 | 32.9% | CN¥351.02 Million | CN¥1.07 Billion | CN¥813.00 Million | CN¥461.98 Million | ▼ -7.4 pp |
| 1997 | 40.4% | CN¥418.34 Million | CN¥1.04 Billion | CN¥807.08 Million | CN¥388.74 Million | ▲ +4.5 pp |
| 1996 | 35.9% | CN¥276.05 Million | CN¥769.62 Million | CN¥740.98 Million | CN¥464.94 Million | ▲ +11.3 pp |
| 1995 | 24.6% | CN¥162.62 Million | CN¥662.32 Million | CN¥609.82 Million | CN¥447.19 Million | ▼ -16.6 pp |
| 1994 | 41.2% | CN¥256.58 Million | CN¥623.47 Million | CN¥503.08 Million | CN¥246.50 Million | ▼ -8.2 pp |
| 1993 | 49.4% | CN¥269.94 Million | CN¥546.67 Million | CN¥518.04 Million | CN¥248.10 Million | ▼ -0.8 pp |
| 1992 | 50.2% | CN¥138.39 Million | CN¥275.56 Million | CN¥441.44 Million | CN¥303.05 Million | — |